BHC
Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 8.19$. Average daily volumn in 3 months 5.25M. Market cap 2.74B
Stock symbol : BHC. Exchange : NYSE. Currency : USD Lastest price : 7.58$. Total volume : 1.84M. Market state POST Click reload if you want to check the lastest price on market!!!
Bausch Health Companies Inc. (BHC)
Last Price
7.58$Change
-0.34Volume
1.84M
| Previous Close | 7.92 |
| Open | 7.96 |
| Day Range | 7.57-7.96 |
| Bid | 7.52 x 1.4k |
| Ask | 7.60 x 1k |
| Volume | 1.84M |
| Average Volume | 5.25M |
| Market Cap | 2.74B |
| Beta | 1.00 |
| 52 Week Range | 4.00-24.24 |
| Trailing P/E | N/A |
| Foward P/E | 1.86 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | 2010-11-10 |
Financial Details
Organization
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment offers Solta pr... oducts, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Latin America, Africa, and the Middle East. The Solta Medical segment offers medical devices. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic, dermatological, and dentistry products in the United States. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Market Cap:
2.74BRevenue:
8.12BTotal Assets:
25.69BTotal Cash:
564M
News about "Bausch Health Companies Inc."
Bausch Health Companies Inc. (BHC) Stock Price and Analyst Predictions
Source from : newsheater - 18 hours ago
The public float for BHC is 344.64M, and at present, short sellers hold a 7.98% of that float. On March 22, 2023, the average trading volume of BHC was 5.51M shares. BHC) stock’s latest price update ...See details»
Bausch Health Companies Inc. (NYSE:BHC) On The Verge Of Breaking Even
Source from : YAHOO!Finance - 4 days ago
Consensus from 7 of the American Pharmaceuticals analysts is that Bausch Health Companies is on the verge of breakeven. They anticipate the company to incur a final loss in 2022, before generating ...See details»
Implied Volatility Surging for Bausch Health (BHC) Stock Options
Source from : YAHOO!Finance - 1 days ago
Investors need to pay close attention to Bausch Health (BHC) stock based on the movements in the options market lately.See details»
Bausch Health Companies Inc
Source from : Reuters - 27 days ago
2021 Legal category Bausch Health plans IPO for medical aesthetics business to cut debt, article with image August 4, 2021 ...See details»
Bausch Health Companies Inc. (BHC) Q4 2022 Earnings Call Transcript
Source from : Seeking Alpha - 27 days ago
Good morning, and welcome to Bausch Health's fourth quarter 2022 earnings ... be comparable to similarly titled measures used by other companies and should be considered along with, but not ...See details»
Bausch Health Companies Inc. (BHC) Stock: What the Analysts are Saying
Source from : newsheater - 6 days ago
Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.” The average price predicted for Bausch Health Companies Inc. (BHC) by analysts ...See details»
Analysts Provide Insight Into Bausch Health Companies Inc.’s (BHC) Potential.
Source from : stocksregister - 7 days ago
Bausch Health Companies Inc. (NYSE:BHC) price on Wednesday, March 15, fall -3.66% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.63. A look at the ...See details»
Bausch Health Cos. Inc.
Source from : Wall Street Journal - 29 days ago
1 Day BHC 6.02% DJIA 0.39% S&P Mid Cap 400 -0.15% Health Care/Life Sciences 0.00% Richard Charles Mulligan Director Bausch Health Cos., Inc., Biogen, Inc., Kadmon Pharmaceuticals LLC, Biogen GmbH ...See details»
Bausch Health's stock soars on solid quarterly results, but we have concerns about the recovery
Source from : CNBC - 27 days ago
Club holding Bausch Health Companies (BHC) on Thursday reported fourth-quarter results ahead of expectations, even as an ongoing patent dispute keeps us skeptical about the stock's ability to ...See details»
Bausch Health Announces Changes to its Board of Directors
Source from : Stockhouse - 21 days ago
LAVAL, QC / ACCESSWIRE / March 1, 2023 / Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of ...See details»
Why Bausch Health Shares Are Trading Higher Today
Source from : Yahoo News - 27 days ago
Bausch Health Companies Inc (NYSE: BHC) reported Q4 revenues of $2.2 billion, flat Y/Y, up 4% organic basis, above the consensus estimate of $2.14 billion. "2022 was a transformative year for Bausch ...See details»
Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up
Source from : Nasdaq - 27 days ago
Shares of Bausch Health Companies Inc. BHC were up 14% in response to fourth-quarter 2022 results. The company’s adjusted earnings per share of $1.02, which beat the Zacks Consensus Estimate of ...See details»
Bausch Health Companies Inc
Source from : Reuters - 11 days ago
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health ...See details»
Bausch Health Companies Inc. 2022 Q4 - Results - Earnings Call Presentation
Source from : Seeking Alpha - 27 days ago
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»